COMPANY

Epalex

HQ: Mountain View, CA source · epalex.com ↗

Keywords: neurology migraine epilepsy

Location: Mountain View, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $1.2M (Form D filed Nov 10, 2025). SEC Form D 0001755010-25-000003 (Nov 10, 2025)
Evidence (1 event)
- Nov 10, 2025 · SEC Form D 0001755010-25-000003
  Name of Issuer: EPALEX Corp; CIK: 1755010; Address: Mountain View, CA; Submission type: D; Filing date: 2025-11-10; Industry Group: Pharmaceuticals; Date of First Sale: 2025-10-31; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3199991; Total Amount Sold: 1200000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals